Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by alabouon Dec 06, 2014 1:28pm

541 Views

Post# 23202767

separate protein business and 4050

Hi everybody,
First post on prometic bullboard thanks to all longers who brings lots of informations.

Does anybodies thinks that PLI will have to separate the 2 business (proteins and 4050) if big pharma wants to invest in PLI if 4050 going forward ?

What could be the impact?

Thanks

Alabou

Bullboard Posts

Critical materials crisis: Diversifying away from China’s monopoly